FDA skeptical of experimental ALS treatment pushed by patient advocates

México Noticias Noticias

FDA skeptical of experimental ALS treatment pushed by patient advocates
México Últimas Noticias,México Titulares
  • 📰 KIRO7Seattle
  • ⏱ Reading Time:
  • 25 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 63%

The Food and Drug Administration meets this week to consider a much-debated treatment for Lou Gehrig’s disease

NurOwn is the clearest test yet of how far the agency may be willing to bend to approve a new medicine for a rare and deadly condition with few treatment options.

The meeting was scheduled after ALS advocates delivered a 30,000-signature petition seeking a public vetting of the treatment. "The amazing testimonials we have seen online do not align with the data that Brainstorm has shared," the group said in a statement. NurOwn is made from stem cells collected from patients' bone marrow. The cells are processed in a lab with biological proteins designed to promote nerve growth, and then injected into the spinal column.

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

KIRO7Seattle /  🏆 271. in US

México Últimas Noticias, México Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

FDA skeptical of experimental ALS treatment pushed by patient advocatesFDA skeptical of experimental ALS treatment pushed by patient advocatesThe Food and Drug Administration meets this week to consider a much-debated treatment for Lou Gehrig’s disease.
Leer más »

FDA skeptical of experimental ALS treatment pushed by patient advocatesFDA skeptical of experimental ALS treatment pushed by patient advocatesThe Food and Drug Administration meets this week to consider a much-debated treatment for Lou Gehrig’s disease
Leer más »

FDA skeptical of experimental ALS treatment pushed by patient advocatesFDA skeptical of experimental ALS treatment pushed by patient advocatesThe Food and Drug Administration meets this week to consider a much-debated treatment for Lou Gehrig’s disease.
Leer más »

FDA skeptical of experimental ALS treatment pushed by patient advocatesFDA skeptical of experimental ALS treatment pushed by patient advocatesThe Food and Drug Administration meets this week to consider a much-debated treatment for Lou Gehrig’s disease.
Leer más »

FDA skeptical of experimental ALS treatment pushed by patient advocatesFDA skeptical of experimental ALS treatment pushed by patient advocatesThe Food and Drug Administration meets this week to consider a much-debated treatment for Lou Gehrig’s disease.
Leer más »

FDA skeptical of experimental ALS treatment pushed by patient advocatesFDA skeptical of experimental ALS treatment pushed by patient advocatesThe Food and Drug Administration meets this week to consider a much-debated treatment for Lou Gehrig’s disease
Leer más »



Render Time: 2025-02-27 08:16:16